The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors

The emergence of cancer immunotherapy has already shown some remarkable results, having changed the treatment strategy in clinical practice for solid tumors. Despite these promising long-term responses, patients seem to lack the ability to respond to immune checkpoint inhibitors, thus demonstrating...

Descripción completa

Detalles Bibliográficos
Autores principales: Koustas, Evangelos, Sarantis, Panagiotis, Papavassiliou, Athanasios G., Karamouzis, Michalis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277892/
https://www.ncbi.nlm.nih.gov/pubmed/32344837
http://dx.doi.org/10.3390/biom10050666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277892/
https://www.ncbi.nlm.nih.gov/pubmed/32344837
http://dx.doi.org/10.3390/biom10050666

Ejemplares similares